Menopause symptoms in HIV-infected and drug-using women

Samantha A. Miller, Nanette Santoro, Yungtai Lo, Andrea A. Howard, Julia H. Arnsten, Michelle Floris-Moore, Galina Moskaleva, Ellie Schoenbaum

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Objective: To examine the association of HIV infection, drug use, and psychosocial stressors with type and frequency of menopause symptoms. Design: In a cross-sectional study, HIV-infected and HIV-uninfected midlife women underwent standardized interviews on menopause status and symptoms, demographic characteristics, depressive symptoms, negative life events, and substance abuse. Body mass index (BMI), HIV serostatus, and CD4 count were measured. Associations between study variables and menopause symptoms were assessed using generalized estimating equations. Results: Of 536 women not on hormone therapy, 48% were black, 42% were Hispanic, 54% were HIV positive, and 30% recently had used illicit drugs. The mean age was 45 ± 5 years; 48% of the women were identified as premenopausal, and 37% were perimenopausal. Psychological symptoms were most prevalent (89%), followed by arthralgias (63%) and vasomotor symptoms (61%). Perimenopausal women reported significantly more menopause symptoms than premenopausal women (ORadj 1.34, 95% CI, 1.09-1.65). HIV-infected women were more likely to report menopause symptoms than uninfected women (ORadj 1.24, 95% CI, 1.02-1.51). Among HIV-infected women not on highly active antiretroviral therapy, symptoms decreased as the CD4 count declined. Increased menopause symptoms were significantly associated with depressive symptoms (ie, Center for Epidemiologic Studies Depression scale score > 23, ORadj1.82, 95% CI, 1.46-2.28), and with experiencing more than three negative life events (ORadj 2.08, 95% CI, 1.54-2.81). Increasing BMI (per kg/m2) was also associated with more menopause symptoms (ORadj 1.03, 95% CI, 1.02-1.05). Conclusion: HIV-infected women reported more menopause symptoms than HIV-uninfected women, but symptoms were less frequent in women with more advanced HIV disease. Depressive symptoms and negative life events were also highly associated with symptoms. Further study of menopause symptoms and HIV-related factors is warranted. Mental health interventions may also have a role in ameliorating menopause symptoms.

Original languageEnglish (US)
Pages (from-to)348-356
Number of pages9
JournalMenopause
Volume12
Issue number3
DOIs
StatePublished - 2005

Fingerprint

Menopause
HIV
Pharmaceutical Preparations
Depression
CD4 Lymphocyte Count
Body Mass Index
Highly Active Antiretroviral Therapy
Arthralgia
Street Drugs
Hispanic Americans
HIV Infections
Substance-Related Disorders
Epidemiologic Studies
Mental Health
Cross-Sectional Studies
Demography
Hormones
Interviews
Psychology

Keywords

  • Drug use
  • HIV
  • Menopause
  • Menopause symptoms

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Menopause symptoms in HIV-infected and drug-using women. / Miller, Samantha A.; Santoro, Nanette; Lo, Yungtai; Howard, Andrea A.; Arnsten, Julia H.; Floris-Moore, Michelle; Moskaleva, Galina; Schoenbaum, Ellie.

In: Menopause, Vol. 12, No. 3, 2005, p. 348-356.

Research output: Contribution to journalArticle

Miller, SA, Santoro, N, Lo, Y, Howard, AA, Arnsten, JH, Floris-Moore, M, Moskaleva, G & Schoenbaum, E 2005, 'Menopause symptoms in HIV-infected and drug-using women', Menopause, vol. 12, no. 3, pp. 348-356. https://doi.org/10.1097/01.GME.0000141981.88782.38
Miller, Samantha A. ; Santoro, Nanette ; Lo, Yungtai ; Howard, Andrea A. ; Arnsten, Julia H. ; Floris-Moore, Michelle ; Moskaleva, Galina ; Schoenbaum, Ellie. / Menopause symptoms in HIV-infected and drug-using women. In: Menopause. 2005 ; Vol. 12, No. 3. pp. 348-356.
@article{799047f21f3449199f0415b9583e8b13,
title = "Menopause symptoms in HIV-infected and drug-using women",
abstract = "Objective: To examine the association of HIV infection, drug use, and psychosocial stressors with type and frequency of menopause symptoms. Design: In a cross-sectional study, HIV-infected and HIV-uninfected midlife women underwent standardized interviews on menopause status and symptoms, demographic characteristics, depressive symptoms, negative life events, and substance abuse. Body mass index (BMI), HIV serostatus, and CD4 count were measured. Associations between study variables and menopause symptoms were assessed using generalized estimating equations. Results: Of 536 women not on hormone therapy, 48{\%} were black, 42{\%} were Hispanic, 54{\%} were HIV positive, and 30{\%} recently had used illicit drugs. The mean age was 45 ± 5 years; 48{\%} of the women were identified as premenopausal, and 37{\%} were perimenopausal. Psychological symptoms were most prevalent (89{\%}), followed by arthralgias (63{\%}) and vasomotor symptoms (61{\%}). Perimenopausal women reported significantly more menopause symptoms than premenopausal women (ORadj 1.34, 95{\%} CI, 1.09-1.65). HIV-infected women were more likely to report menopause symptoms than uninfected women (ORadj 1.24, 95{\%} CI, 1.02-1.51). Among HIV-infected women not on highly active antiretroviral therapy, symptoms decreased as the CD4 count declined. Increased menopause symptoms were significantly associated with depressive symptoms (ie, Center for Epidemiologic Studies Depression scale score > 23, ORadj1.82, 95{\%} CI, 1.46-2.28), and with experiencing more than three negative life events (ORadj 2.08, 95{\%} CI, 1.54-2.81). Increasing BMI (per kg/m2) was also associated with more menopause symptoms (ORadj 1.03, 95{\%} CI, 1.02-1.05). Conclusion: HIV-infected women reported more menopause symptoms than HIV-uninfected women, but symptoms were less frequent in women with more advanced HIV disease. Depressive symptoms and negative life events were also highly associated with symptoms. Further study of menopause symptoms and HIV-related factors is warranted. Mental health interventions may also have a role in ameliorating menopause symptoms.",
keywords = "Drug use, HIV, Menopause, Menopause symptoms",
author = "Miller, {Samantha A.} and Nanette Santoro and Yungtai Lo and Howard, {Andrea A.} and Arnsten, {Julia H.} and Michelle Floris-Moore and Galina Moskaleva and Ellie Schoenbaum",
year = "2005",
doi = "10.1097/01.GME.0000141981.88782.38",
language = "English (US)",
volume = "12",
pages = "348--356",
journal = "Menopause",
issn = "1072-3714",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Menopause symptoms in HIV-infected and drug-using women

AU - Miller, Samantha A.

AU - Santoro, Nanette

AU - Lo, Yungtai

AU - Howard, Andrea A.

AU - Arnsten, Julia H.

AU - Floris-Moore, Michelle

AU - Moskaleva, Galina

AU - Schoenbaum, Ellie

PY - 2005

Y1 - 2005

N2 - Objective: To examine the association of HIV infection, drug use, and psychosocial stressors with type and frequency of menopause symptoms. Design: In a cross-sectional study, HIV-infected and HIV-uninfected midlife women underwent standardized interviews on menopause status and symptoms, demographic characteristics, depressive symptoms, negative life events, and substance abuse. Body mass index (BMI), HIV serostatus, and CD4 count were measured. Associations between study variables and menopause symptoms were assessed using generalized estimating equations. Results: Of 536 women not on hormone therapy, 48% were black, 42% were Hispanic, 54% were HIV positive, and 30% recently had used illicit drugs. The mean age was 45 ± 5 years; 48% of the women were identified as premenopausal, and 37% were perimenopausal. Psychological symptoms were most prevalent (89%), followed by arthralgias (63%) and vasomotor symptoms (61%). Perimenopausal women reported significantly more menopause symptoms than premenopausal women (ORadj 1.34, 95% CI, 1.09-1.65). HIV-infected women were more likely to report menopause symptoms than uninfected women (ORadj 1.24, 95% CI, 1.02-1.51). Among HIV-infected women not on highly active antiretroviral therapy, symptoms decreased as the CD4 count declined. Increased menopause symptoms were significantly associated with depressive symptoms (ie, Center for Epidemiologic Studies Depression scale score > 23, ORadj1.82, 95% CI, 1.46-2.28), and with experiencing more than three negative life events (ORadj 2.08, 95% CI, 1.54-2.81). Increasing BMI (per kg/m2) was also associated with more menopause symptoms (ORadj 1.03, 95% CI, 1.02-1.05). Conclusion: HIV-infected women reported more menopause symptoms than HIV-uninfected women, but symptoms were less frequent in women with more advanced HIV disease. Depressive symptoms and negative life events were also highly associated with symptoms. Further study of menopause symptoms and HIV-related factors is warranted. Mental health interventions may also have a role in ameliorating menopause symptoms.

AB - Objective: To examine the association of HIV infection, drug use, and psychosocial stressors with type and frequency of menopause symptoms. Design: In a cross-sectional study, HIV-infected and HIV-uninfected midlife women underwent standardized interviews on menopause status and symptoms, demographic characteristics, depressive symptoms, negative life events, and substance abuse. Body mass index (BMI), HIV serostatus, and CD4 count were measured. Associations between study variables and menopause symptoms were assessed using generalized estimating equations. Results: Of 536 women not on hormone therapy, 48% were black, 42% were Hispanic, 54% were HIV positive, and 30% recently had used illicit drugs. The mean age was 45 ± 5 years; 48% of the women were identified as premenopausal, and 37% were perimenopausal. Psychological symptoms were most prevalent (89%), followed by arthralgias (63%) and vasomotor symptoms (61%). Perimenopausal women reported significantly more menopause symptoms than premenopausal women (ORadj 1.34, 95% CI, 1.09-1.65). HIV-infected women were more likely to report menopause symptoms than uninfected women (ORadj 1.24, 95% CI, 1.02-1.51). Among HIV-infected women not on highly active antiretroviral therapy, symptoms decreased as the CD4 count declined. Increased menopause symptoms were significantly associated with depressive symptoms (ie, Center for Epidemiologic Studies Depression scale score > 23, ORadj1.82, 95% CI, 1.46-2.28), and with experiencing more than three negative life events (ORadj 2.08, 95% CI, 1.54-2.81). Increasing BMI (per kg/m2) was also associated with more menopause symptoms (ORadj 1.03, 95% CI, 1.02-1.05). Conclusion: HIV-infected women reported more menopause symptoms than HIV-uninfected women, but symptoms were less frequent in women with more advanced HIV disease. Depressive symptoms and negative life events were also highly associated with symptoms. Further study of menopause symptoms and HIV-related factors is warranted. Mental health interventions may also have a role in ameliorating menopause symptoms.

KW - Drug use

KW - HIV

KW - Menopause

KW - Menopause symptoms

UR - http://www.scopus.com/inward/record.url?scp=18644376059&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18644376059&partnerID=8YFLogxK

U2 - 10.1097/01.GME.0000141981.88782.38

DO - 10.1097/01.GME.0000141981.88782.38

M3 - Article

C2 - 15879925

AN - SCOPUS:18644376059

VL - 12

SP - 348

EP - 356

JO - Menopause

JF - Menopause

SN - 1072-3714

IS - 3

ER -